| [1] |
Uncommon Case of Incidentaloma: A Mixed–Combined Functioning
Pheochromocytoma
C. Bergamini
|
| [2] |
A Case of Catecholamine-excess and Cushing's Syndrome Due
to a Corticotropin-secreting Paraganglioma
Holger S. Willenberg
|
| [3] |
A Rare Presentation of Ectopic Cushing’s Syndrome Due
to an ACTH- and CRH-producing Mediastinal Paraganglioma
Angelika Schlamp
|
| [4] |
Clinicopathology and Molecular Genetic Features of Cardiac
Pheochromocytoma
Liang Zhiyong
|
| [5] |
A Pheochromocytoma Presenting
with Acromegaly and Diabetes Mellitus
Wouter W. de Herder
|
| [6] |
Differences in 24-hour AmbulatoryBlood
PressureMonitoring in Subjects with Pheochromocytoma and Essential
Hypertension
Tómas Zelinka
|
| [7] |
Catecholamine Excretion and Circadian Blood Pressure Profile
in Patients with Pheochromocytoma
Zbigniew Gaciong
|
| [8] |
Catecholamine-Secreting Metastatic Carcinoid as Differential
Diagnosis in Pheochromocytoma: Clinical, Laboratory and Imaging
Clues in the Search for the Lurking NET
Andrea L. Long
|
| [9] |
VHL and RET Germline Mutations in Patients Affected by Pheochromocytomas
and/or Paragangliomas
Lisa Simi/Maria Sole Gaglianò
|
| [10] |
Von Hippel-Lindau Gene Mutation in Non-Symdromic Familial
Pheochromocytoma
An-li Tong
|
| [11] |
Somatic and Germline Mosaicism for a R161Q Missense Mutation
in a Patient with Very Mild Phenotype of von Hippel-Lindau
Syndrome (VHL-S)
Salvatore Benvenga
|
| [12] |
An Unusual case of a Compound
Adrenal Medullary Tumor (Pheochromocytoma and Ganglioneuroma)
and an Ipsilateral Cortical Adenoma Due to a Novel VHL Missense
Mutation
Massimo Mannelli
|
| [13] |
Evaluation of Somatic PTEN Mutations
in Pheochromocytoma Patients
Zbigniew Gaciong
|
| [14] |
Novel Pheochromocytoma Susceptibility
Loci Identified by Integrative Genomics
Patricia Dahia
|
| [15] |
Gross Deletions Affecting the SDH
Genes Increase the Percentage of Germline Mutations in Spanish
Pheochromocytoma/Paraganglioma Patients
A. Cascón
|
| [16] |
Tuscany Experience in Defining SDH Role in Patients Affected
By Pheochromocytoma/Paraganglioma
Massimo Mannelli
|
| [17] |
Pediatric Adrenal and Extra-Adrenal Paragangliomas: A Clinicopathologic
Analysis of 34 Patients with Genetic Correlations
V. Nosé
|
| [18] |
Expression of Transforming Growth Factor _ Tumor Necrosis
Factor _ and Their Effects on the Proliferation and Apoptosis
of Human Pheochromocytoma Cells
An-li Tong
|
| [19] |
Expression of Urotensin II and G-Protein Coupled Receptor
14 mRNA in Human Pheochromocytoma Tissues
Zheng-pei Zeng
|
| [20] |
Expression and Processing of the Neuroen Docrine Protein Secretogranin
II in Benign Versus Malignant Pheochromocytomas
Laurent Yon
|
| [21] |
Expression of Connexins in Chromaffin Cells of Normal Human
Adrenals, Benign and Malignant Pheochromocytomas Holger
S. Willenberg
|
| [22] |
Distinct Expression of Galectin-3 in Pheochromocytomas
Oliver Gimm
|
| [23] |
Expression of Activin and Inhibin Subunits, Receptors and
Binding Proteins and Immunohistochemistryof Inhibin _B-subunit
in Human Pheochromocytomas
Wouter W. de Herder
|
| [24] |
Expression of Adrenomedullin and its Receptor mRNA in the
Tissues of Normal Adrenal Medulla and Pheochromocytoma
Zheng-pei Zeng
|
| [25] |
Peptidergic Regulation of Pheochromocytoma: Focusing on Angiogenesis
(VEGFand Its Receptors)
Kazuhiro Takekoshi
|
| [26] |
Tales of a Mysterious Tumor: Neuropeptide Y Expression in
Pheochromocytoma
Susannah Cleary
|
| [27] |
Altered Levels and Location of Noradrenaline Transporter (NAT)
Expression in Phaeochromocytoma
Jacqueline Phillips
|
| [28] |
Differential Expression of Vesicular Monoamine Transporters
and Norepinephrine Transporter in Pheochromocytomas Associated
with von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia
Type 2
Thanh Huynh
|
| [29] |
Transcriptional Regulation of Phenylethanolamine N-methyltransferase
in Pheochromocytomas from Patients with Multiple Endocrine Neoplasia
Type 2 and von Hippel Lindau Syndrome
Thanh Huynh
|
| [30] |
Mouse Pheochromocytoma Cells Modulate Catecholamine Gene Expression
Through Selective Neuronal Nicotinic Receptor Subtypes
Marian J. Evinger
|
| [31] |
The Influence of DHEA on NGF-induced Pheochromocytoma PC12
Cells
Christian G. Ziegler
|
| [32] |
Role of DHEA and Growth Factors in Chromaffin Cell Proliferation
Flavie Sicard
|
| [33] |
Gene-expression Profiling of Rat Pheochromocytomas
Abdel G. Elkahloun
|
| [34] |
Comparison of Heparin and EDTA Plasma for the Measurement
of Catecholamines and Free Metanephrines
Patricia Sullivan
|
| [35] |
Biochemical Diagnosis of Phaeochromocytoma: The Role of Plasma
Metanephrines
Robert T. Peaston
|
| [36] |
Pheochromocytoma Catecholamine Phenotypes and Prediction of
Tumor Size, Location, and Germline Mutation using Plasma Free
Metanephrines
Graeme Eisenhofer
|
| [37] |
Utility of Plasma Free Metanephrines in the Diagnosis of Factitious
Pheochromocytoma
A.R. Chidakel
|
| [38] |
Different Scintigraphic Patterns Between Parasympathetic and
Sympathetic Paragangliomas in Patients with PGL-1
Massimo Mannelli
|
| [39] |
The Sensitivity of123I-MIBG in the Detection of Histologically-Confirmed
Catecholamine-Producing Tumors
Mohamed M. Ismail
|
| [40] |
Adenoviral Vector Transduction of Bovine Chromaffin Cells:Effect
of Cell Survival and Catecholamine Uptake
Shiromi M. Perera
|
| [41] |
Malignant Pheochromocytoma in a Population-Based Study
Håkan Ahlman
|
| [42] |
Using 90Y DOTA TATE Treatment in Patients with Malignant Pheochromocytoma
Anna A. Kasperlik-Zaluska
|
| [43] |
Aspects on Radionuclide Therapy in Malignant Pheochromocytomas
Eva Forssell-Aronsson
|
| [44] |
Chromogranin A as a Useful Biochemical Marker in a Case of
Non-secretory Malignant Paraganglioma Treated with Combined
Chemotherapy
Akiyo Tanabe
|
| [45] |
Expression of c-kit (CD117) in Pheochromocytomas: A Target
for Therapy?
Christian Koch
|
| [46] |
Cell Cycle Regulation in Metastatic Pheochromocytoma
Edwin W. Lai
|
| [47] |
A Hepatic Model of Metastatic Pheochromocytoma
Shoichiro Ohta
|
